BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33970416)

  • 41. Adherence to Recommended Practices for Provision of Long-Acting Reversible Contraception Among Providers in a Large U.S. Health Care System.
    Judge-Golden CP; Wiesenfeld HC; Chen BA; Borrero S
    J Womens Health (Larchmt); 2020 Dec; 29(12):1586-1595. PubMed ID: 32667847
    [No Abstract]   [Full Text] [Related]  

  • 42. Request and fulfillment of postpartum tubal ligation in patients after high-risk pregnancy.
    Albanese A; French M; Gossett DR
    Contraception; 2017 Mar; 95(3):234-238. PubMed ID: 27570140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with long-acting reversible contraception usage: Results from the National Survey of Family Growth.
    Qureshey EJ; Chen HY; Wagner SM; Chauhan SP; Fishel Bartal M
    Int J Gynaecol Obstet; 2023 Apr; 161(1):71-78. PubMed ID: 36181291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Availability and Use of Postpartum LARC in Mexico and Among Hispanics in the United States.
    Potter JE; Hubert C; White K
    Matern Child Health J; 2017 Sep; 21(9):1744-1752. PubMed ID: 27562799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unmet demand for highly effective postpartum contraception in Texas.
    Potter JE; Hopkins K; Aiken AR; Hubert C; Stevenson AJ; White K; Grossman D
    Contraception; 2014 Nov; 90(5):488-95. PubMed ID: 25129329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Rise of Female Sterilization: A Closer Look at Colombia.
    Folch BM; Betstadt S; Li D; Whaley N
    Matern Child Health J; 2017 Sep; 21(9):1772-1777. PubMed ID: 28795311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catholic Hospital Affiliation and Postpartum Contraceptive Care and Subsequent Deliveries.
    Meille G; Monnet JN
    JAMA Intern Med; 2024 May; 184(5):493-501. PubMed ID: 38436965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with never-use of long-acting reversible contraception among adult reproductive-aged women in Ohio.
    Chakraborty P; Chettri S; Gallo MF; Smith MH; Hood RB; Bessett D; Casterline JB; Norris AH; Turner AN
    Perspect Sex Reprod Health; 2023 Mar; 55(1):38-48. PubMed ID: 36336335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
    Rodriguez MI; Skye M; Ramanadhan S; Schrote K; Darney BG
    Contraception; 2022 Aug; 112():61-67. PubMed ID: 34971615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Acting Reversible Contraception Counseling and Use for Older Adolescents and Nulliparous Women.
    Gibbs SE; Rocca CH; Bednarek P; Thompson KMJ; Darney PD; Harper CC
    J Adolesc Health; 2016 Dec; 59(6):703-709. PubMed ID: 27665153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal.
    Bhandari R; Pokhrel KN; Gabrielle N; Amatya A
    PLoS One; 2019; 14(3):e0214590. PubMed ID: 30921403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-Visit Long-Acting Reversible Contraception Initiation Among Adolescents Before and During COVID-19.
    Allison BA; Yates L; Tadikonda A; Arora KS; Stuart GS
    J Adolesc Health; 2024 Feb; 74(2):367-374. PubMed ID: 37815761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statewide quality improvement initiative to implement immediate postpartum long-acting reversible contraception.
    Lacy MM; McMurtry Baird S; Scott TA; Barker B; Zite NB
    Am J Obstet Gynecol; 2020 Apr; 222(4S):S910.e1-S910.e8. PubMed ID: 31838123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unmet need for postpartum long-acting reversible contraception in women with substance use disorders and/or socioeconomic disadvantage.
    Best E; Lokuge B; Dunlop A; Dunford A
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):304-309. PubMed ID: 33619725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of Implementation Science Methodology to Immediate Postpartum Long-Acting Reversible Contraception Policy Roll-Out Across States.
    Rankin KM; Kroelinger CD; DeSisto CL; Pliska E; Akbarali S; Mackie CN; Goodman DA
    Matern Child Health J; 2016 Nov; 20(Suppl 1):173-179. PubMed ID: 27085341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Socioeconomic differences persist in use of permanent vs long-acting reversible contraception: An analysis of the National Survey of Family Growth, 2006 to 2010 vs 2015 to 2017.
    Beshar I; So J; Chelvakumar M; Cahill EP; Shaw KA; Shaw JG
    Contraception; 2021 Apr; 103(4):246-254. PubMed ID: 33359509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of the Delaware Contraceptive Access Now Initiative with Postpartum LARC Use.
    Caudillo ML; Hurtado-Acuna C; Rendall MS; Boudreaux M
    Matern Child Health J; 2022 Aug; 26(8):1657-1666. PubMed ID: 35488950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catholic sole community hospitals are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients.
    Rodriguez MI; Daly A; Meath T; Watson K; McConnell KJ
    Contraception; 2023 Jun; 122():109959. PubMed ID: 36708859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
    Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
    Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.